Neutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.

User menu

You are here

  1. Department of Statistics
  2. Neutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?

Neutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?

TitleNeutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?
Publication TypeJournal Article
Year of Publication1999
AuthorsPaszner, B, Petkau, J, Oger, J
JournalCNS Drugs
Volume11
Pagination225–243